Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mohammed M. Elayan"'
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S143-S144
Background High-dose post-transplantation cyclophosphamide (PTC) has proven to be a valuable treatment modality for the prevention of graft-versus-host disease (GVHD) after stem cell transplant (SCT). Granulocyte colony stimulating factor (G-CSF) is
Autor:
Seema Naik, Jo Meekins, Ashley Simpson, Paul J. Shaughnessy, Richard Lex, Barbara Rush, Carlos Bachier, Mohammed M. Elayan
Publikováno v:
Biology of Blood and Marrow Transplantation. 22(3)
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S391
Autor:
Justin G. Horowitz, Jose M. Magraner, Paul J. Shaughnessy, Mohammed M. Elayan, Carlos Bachier
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(11)
There are limited data available supporting the use of the recombinant granulocyte colony-stimulating factor (G-CSF), tbo-filgrastim, rather than traditionally used filgrastim to mobilize peripheral blood stem cells (PBSC) or to accelerate engraftmen
Publikováno v:
Expert review of clinical pharmacology. 4(6)
Sipuleucel-T is a therapeutic cancer vaccine approved for the treatment of castration- or hormone-refractory prostate cancer. Through a novel process, it activates the body’s own antigen-presenting cells to induce an immune response to prostatic ac
Autor:
Mohammed M. Elayan, Tonya Cox, Jesus G. Berdeja, Rocky Billups, Charles F. LeMaistre, Hana Safah, Carlos Bachier, Peter A. McSweeney
Publikováno v:
Biology of Blood and Marrow Transplantation. 21:S359